Heart surgery brain fog: scientists hunt for a blood test to predict it
NCT ID NCT07231731
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 48 older adults having heart bypass surgery to see if a small molecule called microRNA-151-5p is linked to memory and thinking problems after the operation. Researchers measured levels of this molecule and inflammation in the blood before and after surgery, and tested thinking skills daily. The goal was to understand why some people experience cognitive decline after heart surgery and find early warning signs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
48 people
The number who actually took part.
- Started
-
May 2022
- Finished
-
Oct 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients undergoing coronary artery bypass grafting surgery at the Department of Cardiac and Thoracic Surgery of the Clinic for Surgery, Clinical Hospital Center Osijek.
- Ages
-
65 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patients undergoing coronary artery bypass graft surgery to treat coronary artery disease * two or more coronary bypass surgery with the use of extracorporeal circulation * patients between the ages of 65 and 80 * patients according to the classification of the American Society of Anesthesiologists (ASA) classified in groups III and IV * patients who agreed to participate in the research and signed an informed consent Exclusion Criteria: * patients with communication difficulties (severe visual, hearing and speech impairment) * illiterate patients * patients with a history of dementia, schizophrenia, Parkinson's disease, Alzheimer's disease, alcoholism * patients with previously known liver failure of any grade according to the Child-Pough classification * patients with previously known renal failure greater than grade 2 * patients taking immunosuppressive, corticosteroid and anticholinergic therapy * intraoperatively used cell-saver and/or hemofilter * patients in whom the planned procedure is not performed * patients in whom it is not possible to assess cognitive functions postoperatively (patients sedated due to intra- or postoperative surgical complications)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Biomarkers are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Osijek
Osijek, 31000, Croatia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can donated immune cells calm the cytokine storm?
- Your smartwatch could soon warn you before you crash
- Can biomarkers flag kidney risk before heart surgery?
- Your health Data's hidden patterns: can they predict what happens next?
- Could your heart hold the key to Alzheimer's prevention?
- Zirconia vs titanium: which dental implant heals bone better?